CMS' 2025 Final Rule included an increased payment for Intrinsic Therapeutics' Barricaid device, according to a Nov. 12 news release.
A live webcast of the presentation will be available on the Events and Presentations section of Bicara’s website at www.bicara.com. An archived replay of the webcast will be available for ...
Bicara Therapeutics is a clinical-stage biopharmaceutical company ... potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and ...
The Mectizan Donation Program applauds Timor-Leste for eliminating lymphatic filariasis (LF) as a public health problem, a remarkable achievement that was recently validated by the World Health ...
QBE North America today announced the release of its 2024 Digital Health Insurance Report, which shares insights from insurance brokers on the risks associated with using digital health services like ...
HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Completed upsized initial public offering, raising approximately $362 million in gross proceeds, with full ...
Q3 2024 Earnings Call Transcript November 7, 2024 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
At this time, all participants are in a listen-only mode. Later, there will be a question-and-answer session, and instructions will be given at that time. Please note that today's call is being ...
Mind Medicine’s share price has responded very strongly to Q3 update that contained very little new information. Read why I ...
Detailed price information for Oncotelic Therapeutics Inc (OTLC) from The Globe and Mail including charting and trades.
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the clinical launch of its Immune Profile Score (IPS) ...
A central question in adult stem cell biology is elucidating the signaling pathways regulating their dynamics and function in diverse physiological and age-related contexts. Muscle stem cells in ...